Ceftriaxone Ipharma 500 mg, 1 000 mg, Intravenous (IV) injection
PDF Leaflet Revision Date: 20 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various bacterial infections.
Dosage (summary)
Adults: 1-2 g once daily; severe cases: up to 4 g. Children: 20-80 mg/kg once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy not established; excreted in breast milk.
Key Drug Interactions
- Calcium-containing products
- Oral anticoagulants
- Aminoglycosides
Contraindications
- Hypersensitivity to ceftriaxone
- Severe hypersensitivity to beta-lactams
- Premature neonates
- Full-term neonates with hyperbilirubinaemia
Common side effects
- Eosinophilia
- Leukopenia
- Diarrhoea
- Rash
Counselling Points
- Report any allergic reactions
- Avoid mixing with calcium solutions
- Monitor for signs of superinfection
Serious warnings
- Serious hypersensitivity reactions
- Risk of biliary precipitation
- Jarisch-Herxheimer reaction
Important Disclaimer
The Ceftriaxone Ipharma 500 mg, 1 000 mg, Intravenous (IV) injection professional information leaflet below is the property of Ipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
